Chitosan Hemostatic Powder Market Size, Share, Trends & Forecast
The Chitosan Hemostatic Powder Market was estimated at approximately USD 0.63 billion in 2023 and is being supported by increasing demand for effective bleeding-control products across surgical, trauma, dental, and wound-care applications. Chitosan-based hemostatic products are attracting attention because of their ability to support rapid hemostasis and their suitability for different healthcare settings.
Surgical hemostasis represents an important application area for chitosan hemostatic powder. Surgeons can use topical hemostatic products to help manage bleeding during procedures, particularly when conventional methods may be difficult to apply.
Trauma hemostasis is another significant area of opportunity. Emergency-care environments require products that can be applied quickly, making portable and easy-to-use hemostatic formulations valuable for managing bleeding.
Dental hemostasis is also contributing to market development. Chitosan-based products can be used in dental procedures where bleeding control is an important part of patient care and post-procedure management.
Wound care represents another growing application. Advanced hemostatic products can support bleeding management in different types of wounds while complementing conventional wound-treatment approaches.
Continued research into chitosan formulations, product performance, and delivery formats is expected to create opportunities for manufacturers developing next-generation hemostatic solutions.